You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Litigation Details for The Trustees of Purdue University v. STMicroelectronics International N.V. (W.D. Tex. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in The Trustees of Purdue University v. STMicroelectronics International N.V.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , and ⤷  Get Started Free .

Litigation Summary and Analysis for The Trustees of Purdue University v. STMicroelectronics International N.V. | Case No. 6:21-cv-00727

Last updated: August 13, 2025


Introduction

The lawsuit The Trustees of Purdue University v. STMicroelectronics International N.V., filed in the United States District Court for the Western District of Texas (Case No. 6:21-cv-00727), underscores ongoing complexities in intellectual property rights, patent infringement, and licensing disputes within the semiconductor and technology sectors. Purdue University, a leading research institution, alleges that STMicroelectronics International N.V. (“STMicroelectronics”) infringed upon Purdue’s patent rights concerning semiconductor fabrication technologies, prompting a multifaceted legal confrontation.


Case Background and Allegations

Purdue University's Patent Rights

Purdue University, renowned for its extensive research in electronics and semiconductors, holds multiple patents covering specific processes and devices related to semiconductor manufacturing and electronic circuit designs. These patents reflect Purdue's strategic investments in foundational technologies (patent numbers and filings are publicly accessible through the USPTO). The university claims that its patents are vital to the development of high-performance chip architectures, serving significant commercial interests.

Claims Against STMicroelectronics

The core allegation concerns STMicroelectronics’ sale and use of semiconductor components that allegedly infringe Purdue’s patent rights. Specifically, Purdue alleges that STMicroelectronics:

  • Utilized patented fabrication processes without licensing agreements.
  • Manufactured semiconductor devices incorporating Purdue’s protected technologies.
  • Engaged in activities that violate Purdue’s patent rights internationally, including within the U.S.

In its complaint, Purdue seeks declaratory judgments of patent infringement, injunctive relief to prevent ongoing infringement, a halt to sales of infringing devices, and monetary damages reflective of STMicroelectronics’ alleged unauthorized use.


Legal Dimensions and Proceedings

Patent Infringement Analysis

The case hinges on the validity and enforceability of Purdue’s patents concerning semiconductor processes. Purdue bears the burden of proving that:

  • Its patents are valid and non-obvious.
  • STMicroelectronics’ products or processes infringe upon those patents.

STMicroelectronics, in turn, has the opportunity to challenge patent validity through invalidity defenses, including prior art references or asserting that Purdue’s patents are indefinite or improperly issued.

Jurisdiction and International Considerations

The lawsuit being filed in Texas indicates Purdue’s assertion of jurisdiction based on the sale of infringing devices within U.S. markets. Given the multinational nature of the parties, issues related to extraterritorial rights, compliance with international patent laws, and enforcement mechanisms are central.

Potential Patent Litigation Strategies

In patent disputes like this, STMicroelectronics may employ legal tactics:

  • Challenging Purdue’s patent validity via reexamination or post-grant procedures.
  • Asserting that the patents do not cover the accused devices.
  • Demonstrating non-infringement through technical expert testimony.
  • Negotiating licensing agreements to resolve the dispute amicably.

Court Procedural Aspects and Timeline

The case’s progression involves preliminary motions—such as motions to dismiss or for summary judgment—and discovery phases, during which technical documents, manufacturing processes, and patent validity evidence are exchanged. The court may also set settlement conferences given the high stakes.


Implications for the Semiconductor Industry

Patent Litigation as a Competitive Tool

Litigation such as this exemplifies how patent rights serve as strategic assets within the semiconductor industry. Purdue’s assertion protects its intellectual property while reinforcing the value of its R&D investments.

Impact on Innovation and Licensing

Success for Purdue could lead to increased licensing revenues, strategic licensing negotiations, and heightened patent enforcement across the industry. Conversely, STMicroelectronics’ defense strategies might influence broader patent validity doctrines or licensing practices.

Potential for Cross-Licensing Agreements

Given the technical intricacies and mutual interests, the parties may explore cross-licensing arrangements or alternative dispute resolution mechanisms, such as arbitration, to mitigate lengthy and costly litigation.

Regulatory and Policy Considerations

This case also touches on patent policy, the balance between protecting innovation and avoiding patent thickets that hinder technological progress. Courts’ rulings could influence patent standards and licensing norms in the highly complex and patent-intensive semiconductor market.


Legal and Business Significance

The litigation highlights the critical importance of:

  • Robust patent portfolio management as a safeguard against infringement claims.
  • Precise patent drafting to withstand validity challenges.
  • Strategic litigation to protect competitive advantages.
  • Due diligence when utilizing or licensing patented technologies.

Purdue’s proactive stance underscores its efforts to defend proprietary innovations against competitors and protect its R&D investments. For STMicroelectronics, defense strategies may involve seeking to invalidate Purdue’s patents or demonstrating non-infringement.


Conclusion

The case The Trustees of Purdue University v. STMicroelectronics exemplifies the intricate intersection of patent law, global manufacturing, and technological innovation. Given the high stakes, the litigation's outcome could have broad implications for patent enforcement practices within the semiconductor industry, influencing licensing strategies, patent valuation, and innovation policies.


Key Takeaways

  • Strategic Patent Enforcement: Purdue's litigation underscores the vital role of protecting research-driven patents in securing commercialization rights and revenue streams.
  • Complexity of Patent Validity: Patent validity remains a central contested issue, often requiring extensive technical and legal scrutiny.
  • Industry Impact: Litigation sets precedents affecting licensing negotiations, patent strategies, and innovation investments in the semiconductor field.
  • Cross-Jurisdictional Challenges: Multinational patent enforcement involves navigating differing legal standards, emphasizing the importance of comprehensive IP portfolios.
  • Proactive Litigation as a Business Tool: Companies leverage patent lawsuits not only to defend proprietary rights but also to influence market competition and technology development pathways.

FAQs

1. What are the main legal claims Purdue University is making against STMicroelectronics?
Purdue alleges patent infringement based on STMicroelectronics’ use and sale of semiconductor products that allegedly incorporate Purdue’s patented processes and devices. The university seeks declaratory judgments, injunctive relief, and damages.

2. How can STMicroelectronics defend against Purdue’s patent infringement claims?
STMicroelectronics can challenge the validity of Purdue's patents, argue non-infringement through technical defenses, or seek to negotiate a licensing agreement. They may also pursue invalidity arguments via patent reexamination or post-grant proceedings.

3. What impact could this litigation have on the semiconductor industry?
The case can influence patent enforcement practices, licensing strategies, and technological innovation. It may also set legal precedents regarding semiconductor patent validity and enforceability.

4. How do multinational patent disputes complicate legal proceedings?
Cross-border enforcement, differing legal standards, and international treaties create additional complexity, requiring comprehensive legal and strategic planning to protect patent rights globally.

5. What should companies learn from this litigation?
Maintaining robust patent portfolios, investing in clear patent drafting, and engaging in proactive enforcement are essential for safeguarding intellectual property in competitive sectors like semiconductors.


Sources

  1. U.S. Patent and Trademark Office (USPTO) database for patent details.
  2. Court filings and case docket (public record).
  3. Industry analysis reports on patent litigation trends in semiconductors.
  4. Legal commentaries on patent enforcement and validity challenges.

[Note: The above analysis is based on publicly available information about the case and general industry understanding. Specific procedural developments and court rulings may influence the case trajectory.]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.